These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 1531481)
21. beta-VLDL and acetylated-LDL binding to pigeon monocyte macrophages. Henson DA; St Clair RW; Lewis JC Atherosclerosis; 1989 Jul; 78(1):47-60. PubMed ID: 2667527 [TBL] [Abstract][Full Text] [Related]
22. Isolation, characterization, and uptake in human fibroblasts of an apo(a)-free lipoprotein obtained on reduction of lipoprotein(a). Armstrong VW; Walli AK; Seidel D J Lipid Res; 1985 Nov; 26(11):1314-23. PubMed ID: 2999280 [TBL] [Abstract][Full Text] [Related]
23. Oxidative modification of lipoprotein(a) and the effect of beta-carotene. Naruszewicz M; Selinger E; Davignon J Metabolism; 1992 Nov; 41(11):1215-24. PubMed ID: 1435294 [TBL] [Abstract][Full Text] [Related]
24. Involvement of the macrophage low density lipoprotein receptor-binding domains in the uptake of oxidized low density lipoprotein. Keidar S; Brook GJ; Rosenblat M; Fuhrman B; Dankner G; Aviram M Arterioscler Thromb; 1992 Apr; 12(4):484-93. PubMed ID: 1373074 [TBL] [Abstract][Full Text] [Related]
25. Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages. Hazell LJ; Stocker R Biochem J; 1993 Feb; 290 ( Pt 1)(Pt 1):165-72. PubMed ID: 8439285 [TBL] [Abstract][Full Text] [Related]
26. Oxidative modification of Lp(a) causes changes in the structure and biological properties of apo(a). Naruszewicze M; Giroux LM; Davignon J Chem Phys Lipids; 1994 Jan; 67-68():167-74. PubMed ID: 8187211 [TBL] [Abstract][Full Text] [Related]
27. Glycation of low-density lipoprotein results in the time-dependent accumulation of cholesteryl esters and apolipoprotein B-100 protein in primary human monocyte-derived macrophages. Brown BE; Rashid I; van Reyk DM; Davies MJ FEBS J; 2007 Mar; 274(6):1530-41. PubMed ID: 17480204 [TBL] [Abstract][Full Text] [Related]
28. The interaction of carbamylated low-density lipoprotein with cultured cells. Studies with human fibroblasts, rat peritoneal macrophages and human monocyte-derived macrophages. Gonen B; Cole T; Hahm KS Biochim Biophys Acta; 1983 Nov; 754(2):201-7. PubMed ID: 6317041 [TBL] [Abstract][Full Text] [Related]
29. Phospholipase D-modified low density lipoprotein is taken up by macrophages at increased rate. A possible role for phosphatidic acid. Aviram M; Maor I J Clin Invest; 1993 May; 91(5):1942-52. PubMed ID: 8486764 [TBL] [Abstract][Full Text] [Related]
30. Oxidized lipoprotein (a) induces cell adhesion molecule Mac-1 (CD 11b) and enhances adhesion of the monocytic cell line U937 to cultured endothelial cells. Ragab MS; Selvaraj P; Sgoutas DS Atherosclerosis; 1996 Jun; 123(1-2):103-13. PubMed ID: 8782841 [TBL] [Abstract][Full Text] [Related]
31. Interactions of low density lipoprotein2 and other apolipoprotein B-containing lipoproteins with lipoprotein(a). Ye SQ; Trieu VN; Stiers DL; McConathy WJ J Biol Chem; 1988 May; 263(13):6337-43. PubMed ID: 2966154 [TBL] [Abstract][Full Text] [Related]
32. Enzymatically degraded LDL preferentially binds to CD14(high) CD16(+) monocytes and induces foam cell formation mediated only in part by the class B scavenger-receptor CD36. Kapinsky M; Torzewski M; Büchler C; Duong CQ; Rothe G; Schmitz G Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):1004-10. PubMed ID: 11397711 [TBL] [Abstract][Full Text] [Related]
33. Effect of dietary supplementation of beta-carotene on human monocyte-macrophage-mediated oxidation of low density lipoprotein. Levy Y; Kaplan M; Ben-Amotz A; Aviram M Isr J Med Sci; 1996 Jun; 32(6):473-8. PubMed ID: 8682654 [TBL] [Abstract][Full Text] [Related]
34. Lipoprotein receptor interactions are not required for monocyte oxidation of LDL. Cathcart MK; Li Q; Chisolm GM J Lipid Res; 1995 Sep; 36(9):1857-65. PubMed ID: 8558074 [TBL] [Abstract][Full Text] [Related]
35. The intracellular storage and turnover of apolipoprotein B of oxidized LDL in macrophages. Jessup W; Mander EL; Dean RT Biochim Biophys Acta; 1992 Jun; 1126(2):167-77. PubMed ID: 1627619 [TBL] [Abstract][Full Text] [Related]
36. Exogenous GM3 ganglioside inhibits atherosclerosis via multiple steps: A potential atheroprotective drug. Ao M; Wang K; Zhou X; Chen G; Zhou Y; Wei B; Shao W; Huang J; Liao H; Wang Z; Sun Y; Zeng S; Chen Y Pharmacol Res; 2019 Oct; 148():104445. PubMed ID: 31526872 [TBL] [Abstract][Full Text] [Related]
37. Triglyceride Rich Lipoprotein -LPL-VLDL Receptor and Lp(a)-VLDL Receptor Pathways for Macrophage Foam Cell Formation. Takahashi S J Atheroscler Thromb; 2017 Jun; 24(6):552-559. PubMed ID: 28428482 [TBL] [Abstract][Full Text] [Related]
38. Heterogeneity of human lipoprotein Lp[a]: cytochemical and biochemical studies on the interaction of two Lp[a] species with the LDL receptor. Armstrong VW; Harrach B; Robenek H; Helmhold M; Walli AK; Seidel D J Lipid Res; 1990 Mar; 31(3):429-41. PubMed ID: 2140397 [TBL] [Abstract][Full Text] [Related]